NCCN Guidelines® insights cancer-associated venous thromboembolic disease, version 2.2018 featured updates to the NCCN guidelines

Michael B. Streiff, Bjorn Holmstrom, Dana Angelini, Aneel Ashrani, Paula L. Bockenstedt, Carolyn Chesney, John Fanikos, Randolph B. Fenninger, Annemarie E. Fogerty, Shuwei Gao, Samuel Z. Goldhaber, Krishna Gundabolu, Paul Hendrie, Alfred I. Lee, Jason T. Lee, Janelle Mann, Brandon McMahon, Michael M. Millenson, Colleen Morton, Thomas L. OrtelSadat Ozair, Rita Paschal, Sanford Shattil, Tanya Siddiqi, Kristi J. Smock, Gerald Soff, Tzu Fei Wang, Eliot Williams, Anaadriana Zakarija, Lydia Hammond, Mary A. Dwyer, Anita M. Engh

Research output: Contribution to journalArticle

53 Scopus citations

Abstract

Venous thromboembolism (VTE) is common in patients with cancer and increases morbidity and mortality. VTE prevention and treatment are more complex in patients with cancer. The NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease outline strategies for treatment and prevention of VTE in adult patients diagnosed with cancer or in whom cancer is clinically suspected. These NCCN Guidelines Insights explain recent changes in anticoagulants recommended for the treatment of cancer-associated VTE.

Original languageEnglish (US)
Pages (from-to)1289-1303
Number of pages15
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume16
Issue number11
DOIs
StatePublished - Nov 1 2018

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'NCCN Guidelines<sup>®</sup> insights cancer-associated venous thromboembolic disease, version 2.2018 featured updates to the NCCN guidelines'. Together they form a unique fingerprint.

  • Cite this

    Streiff, M. B., Holmstrom, B., Angelini, D., Ashrani, A., Bockenstedt, P. L., Chesney, C., Fanikos, J., Fenninger, R. B., Fogerty, A. E., Gao, S., Goldhaber, S. Z., Gundabolu, K., Hendrie, P., Lee, A. I., Lee, J. T., Mann, J., McMahon, B., Millenson, M. M., Morton, C., ... Engh, A. M. (2018). NCCN Guidelines® insights cancer-associated venous thromboembolic disease, version 2.2018 featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 16(11), 1289-1303. https://doi.org/10.6004/jnccn.2018.0084